In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  omega-3 fatty acid
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 900/429/1, NCT00790140

2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 30 to 65
Sponsor: Other
Protocol IDs: 88-04-27-9683, NCT01049295

3.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NKP_CA_04, NCT01596933

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: SWOG-S0927, S0927, NCT01385137

5.

Phase: Phase III
Type: Prevention
Status: Active
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 2009P-001217, NCT01169259

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Dietary intervention FL, NCT00455416

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MU9230, NCT00899353

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09/H0408/51, EudraCT number 2009-009470027, UHL trial number 10720, NCT01019382

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764

10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-10024, NCT01282580

11.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000538993, DFCI-03116, 03-116, NCT00458549

12.

Phase: No phase specified
Type: Prevention
Status: Active
Age: 35 to 70
Sponsor: Other
Protocol IDs: 26970, NCT00723398

13.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 85108, NCI-2009-01340, IRB00009305, NCT00996749

14.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 10097, REC reference: 06/Q2501/160, EudraCT number: 2006-000044-71, NCT00942292

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 70
Sponsor: Other
Protocol IDs: PHO-0702, NCT01127867

16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-11022, NCI-2011-03262, NCT01478477

17.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 35 to 75
Sponsor: Other
Protocol IDs: INAF-2010-H09-10-114, NCT01653925
New Search